Piper Sandler Maintains Overweight on Innovex International, Raises Price Target to $27

Benzinga · 2d ago
Piper Sandler analyst Derek Podhaizer maintains Innovex International (NYSE:INVX) with a Overweight and raises the price target from $20 to $27.